Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome
- PMID: 8079968
- DOI: 10.1016/s0272-6386(12)80899-7
Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome
Abstract
Infection has been recognized as an important cause of morbidity and mortality in children with nephrotic syndrome. However, the incidence and severity of infection and the mechanisms responsible for the increased susceptibility to infection are still unclear in adults. We studied 86 consecutive adult patients with nephrotic syndrome but no diabetic nephropathy. Risk factors for infection were evaluated by logistic regression analysis. Infections were found in 16 patients (19%), of whom six died of infection and two developed end-stage renal failure associated with infection. The relative risk for bacterial infection among patients with serum immunoglobulin G (IgG) levels below 600 mg/dL was 6.74 compared with that for patients with serum IgG levels over 600 mg/dL (95% confidence interval, 1.22 to 36.32; P = 0.029). In patients with serum creatinine levels over 2.0 mg/dL, the relative risk of bacterial infection was 5.31 compared with patients with serum creatinine levels below 2.0 mg/dL (95% confidence interval, 1.08 to 26.09; P = 0.040). Intravenous immunoglobulin (10 to 15 g) was administered prospectively every 4 weeks to 18 patients with serum IgG levels below 600 mg/dL until serum IgG levels increased to over 600 mg/dL. Administration of immunoglobulin resulted in a decreased rate of bacterial infections to a level equal to that in patients with endogenous levels over 600 mg/dL. These data indicate that hypogammaglobulinemia and renal insufficiency are independent risk factors for bacterial infection in adult patients with nephrotic syndrome. The effects of intravenous immunoglobulin suggest that maintenance of serum IgG levels over 600 mg/dL may reduce the risk of infection.
Similar articles
-
Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.J Clin Immunol. 2017 Apr;37(3):311-318. doi: 10.1007/s10875-017-0379-5. Epub 2017 Mar 21. J Clin Immunol. 2017. PMID: 28321612
-
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.Clin Immunol. 2010 Oct;137(1):21-30. doi: 10.1016/j.clim.2010.06.012. Epub 2010 Aug 1. Clin Immunol. 2010. PMID: 20675197
-
[Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].Arch Pediatr. 2006 Jul;13(7):1034-9. doi: 10.1016/j.arcped.2006.03.152. Epub 2006 May 18. Arch Pediatr. 2006. PMID: 16713207 French.
-
If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia.J Allergy Clin Immunol Pract. 2025 Mar;13(3):511-521. doi: 10.1016/j.jaip.2024.12.024. Epub 2024 Dec 24. J Allergy Clin Immunol Pract. 2025. PMID: 39725313 Review.
-
Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.Immunol Allergy Clin North Am. 2019 Feb;39(1):95-111. doi: 10.1016/j.iac.2018.08.001. Immunol Allergy Clin North Am. 2019. PMID: 30466775 Review.
Cited by
-
The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.Pediatr Nephrol. 2014 Jul;29(7):1159-67. doi: 10.1007/s00467-013-2567-8. Epub 2013 Aug 30. Pediatr Nephrol. 2014. PMID: 23989393 Review.
-
Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome.J Int Med Res. 2017 Dec;45(6):2139-2145. doi: 10.1177/0300060517715339. Epub 2017 Jun 29. J Int Med Res. 2017. PMID: 28661269 Free PMC article.
-
Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.Arthritis Res Ther. 2015 Apr 3;17(1):92. doi: 10.1186/s13075-015-0603-8. Arthritis Res Ther. 2015. PMID: 25890338 Free PMC article.
-
Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.Front Physiol. 2019 Jan 15;9:1868. doi: 10.3389/fphys.2018.01868. eCollection 2018. Front Physiol. 2019. PMID: 30697163 Free PMC article. Review.
-
Relapse and its remission in Japanese patients with idiopathic membranous nephropathy.Clin Exp Nephrol. 2015 Apr;19(2):278-83. doi: 10.1007/s10157-014-0987-9. Epub 2014 Jun 24. Clin Exp Nephrol. 2015. PMID: 24953847
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical